119 related articles for article (PubMed ID: 28100842)
1. Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia.
Stelmach P; Błoński JZ; Wawrzyniak E; Schweiger PE; Wilandt A; Majak PE; Robak T
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1321-1330. PubMed ID: 28100842
[TBL] [Abstract][Full Text] [Related]
2. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
Hallek M; Langenmayer I; Nerl C; Knauf W; Dietzfelbinger H; Adorf D; Ostwald M; Busch R; Kuhn-Hallek I; Thiel E; Emmerich B
Blood; 1999 Mar; 93(5):1732-7. PubMed ID: 10029603
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.
Di Raimondo F; Giustolisi R; Lerner S; Cacciola E; O'Brien S; Kantarjian H; Keating MJ
Ann Oncol; 2001 May; 12(5):621-5. PubMed ID: 11432619
[TBL] [Abstract][Full Text] [Related]
5. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
[TBL] [Abstract][Full Text] [Related]
6. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
Rivkina A; Vitols G; Murovska M; Lejniece S
Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
[TBL] [Abstract][Full Text] [Related]
7. Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia.
Källander CF; Simonsson B; Hagberg H; Gronowitz JS
Cancer; 1984 Dec; 54(11):2450-5. PubMed ID: 6498737
[TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer.
Felix K; Hinz U; Dobiasch S; Hackert T; Bergmann F; Neumüller M; Gronowitz S; Bergqvist M; Strobel O
Pancreas; 2018 Jan; 47(1):72-79. PubMed ID: 29189449
[TBL] [Abstract][Full Text] [Related]
10. Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.
Molica S; Giannarelli D; Mirabelli R; Levato L; Russo A; Linardi M; Gentile M; Morabito F
Eur J Haematol; 2016 Jan; 96(1):72-7. PubMed ID: 25819739
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia.
Itälä M; Pelliniemi TT; Remes K
Br J Haematol; 1996 Jul; 94(1):129-32. PubMed ID: 8757522
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
14. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL.
Magnac C; Porcher R; Davi F; Nataf J; Payelle-Brogard B; Tang RP; Oppezzo P; Lévy V; Dighiero G; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jan; 17(1):133-7. PubMed ID: 12529670
[TBL] [Abstract][Full Text] [Related]
16. Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT.
Bacovsky J; Myslivecek M; Minarik J; Scudla V; Pika T; Zapletalova J; Petrova P; Bartkova M; Adam T; Gronowitz SJ
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):135-8. PubMed ID: 24572488
[TBL] [Abstract][Full Text] [Related]
17. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
[TBL] [Abstract][Full Text] [Related]
18. [Clinical application of thymidine kinase activity in patients with acute non-lymphocytic leukemia].
Sampi K; Takagi T; Sakai C; Kuraishi Y; Ishige K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):69-73. PubMed ID: 1987902
[TBL] [Abstract][Full Text] [Related]
19. Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia.
Szánthó E; Bhattoa HP; Csobán M; Antal-Szalmás P; Újfalusi A; Kappelmayer J; Hevessy Z
PLoS One; 2014; 9(3):e91647. PubMed ID: 24621590
[TBL] [Abstract][Full Text] [Related]
20. Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia.
Källander CF; Simonsson B; Gronowitz JS; Nilsson K
Eur J Haematol; 1987 Apr; 38(4):331-7. PubMed ID: 3609253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
